ETAO International Co., Ltd.
ETAO International Co., Ltd. ETAO Peers
See (ETAO) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ETAO | $1.91 | -31.79% | 9.8M | -0.01 | -$175.64 | N/A |
| VEEV | $282.61 | -0.10% | 46.2B | 60.10 | $4.70 | N/A |
| GEHC | $76.12 | +0.22% | 34.9B | 15.99 | $4.76 | +0.17% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | +0.17% |
| DOCS | $59.31 | +1.59% | 11.1B | 53.44 | $1.11 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $101.28 | -1.56% | 8.8B | 73.91 | $1.37 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| BTSG | $22.00 | -1.21% | 3.9B | 81.52 | $0.27 | N/A |
| BTSGU | $77.02 | -3.30% | 3.8B | N/A | N/A | N/A |
Stock Comparison
ETAO vs VEEV Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, VEEV has a market cap of 46.2B. Regarding current trading prices, ETAO is priced at $1.91, while VEEV trades at $282.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas VEEV's P/E ratio is 60.10. In terms of profitability, ETAO's ROE is -13.69%, compared to VEEV's ROE of +0.14%. Regarding short-term risk, ETAO is more volatile compared to VEEV. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs GEHC Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, GEHC has a market cap of 34.9B. Regarding current trading prices, ETAO is priced at $1.91, while GEHC trades at $76.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas GEHC's P/E ratio is 15.99. In terms of profitability, ETAO's ROE is -13.69%, compared to GEHC's ROE of +0.26%. Regarding short-term risk, ETAO is more volatile compared to GEHC. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs GEHCV Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, ETAO is priced at $1.91, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas GEHCV's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to GEHCV's ROE of +0.26%. Regarding short-term risk, ETAO is more volatile compared to GEHCV. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs DOCS Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, DOCS has a market cap of 11.1B. Regarding current trading prices, ETAO is priced at $1.91, while DOCS trades at $59.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas DOCS's P/E ratio is 53.44. In terms of profitability, ETAO's ROE is -13.69%, compared to DOCS's ROE of +0.22%. Regarding short-term risk, ETAO is more volatile compared to DOCS. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SGFY Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, ETAO is priced at $1.91, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SGFY's P/E ratio is 70.91. In terms of profitability, ETAO's ROE is -13.69%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, ETAO is more volatile compared to SGFY. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs HQY Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, ETAO is priced at $1.91, while HQY trades at $101.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HQY's P/E ratio is 73.91. In terms of profitability, ETAO's ROE is -13.69%, compared to HQY's ROE of +0.06%. Regarding short-term risk, ETAO is more volatile compared to HQY. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs RCM Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, ETAO is priced at $1.91, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas RCM's P/E ratio is -102.21. In terms of profitability, ETAO's ROE is -13.69%, compared to RCM's ROE of -0.02%. Regarding short-term risk, ETAO is more volatile compared to RCM. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs BTSG Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BTSG has a market cap of 3.9B. Regarding current trading prices, ETAO is priced at $1.91, while BTSG trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BTSG's P/E ratio is 81.52. In terms of profitability, ETAO's ROE is -13.69%, compared to BTSG's ROE of +0.03%. Regarding short-term risk, ETAO is more volatile compared to BTSG. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs BTSGU Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BTSGU has a market cap of 3.8B. Regarding current trading prices, ETAO is priced at $1.91, while BTSGU trades at $77.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BTSGU's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to BTSGU's ROE of +0.03%. Regarding short-term risk, ETAO is more volatile compared to BTSGU. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs ONEM Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, ETAO is priced at $1.91, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ONEM's P/E ratio is -7.77. In terms of profitability, ETAO's ROE is -13.69%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, ETAO is more volatile compared to ONEM. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs PRVA Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, ETAO is priced at $1.91, while PRVA trades at $21.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas PRVA's P/E ratio is 182.67. In terms of profitability, ETAO's ROE is -13.69%, compared to PRVA's ROE of +0.02%. Regarding short-term risk, ETAO is more volatile compared to PRVA. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs WGS Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, WGS has a market cap of 2.6B. Regarding current trading prices, ETAO is priced at $1.91, while WGS trades at $89.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas WGS's P/E ratio is -64.55. In terms of profitability, ETAO's ROE is -13.69%, compared to WGS's ROE of -0.17%. Regarding short-term risk, ETAO is more volatile compared to WGS. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs CERT Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CERT has a market cap of 1.9B. Regarding current trading prices, ETAO is priced at $1.91, while CERT trades at $11.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CERT's P/E ratio is -574.00. In terms of profitability, ETAO's ROE is -13.69%, compared to CERT's ROE of -0.00%. Regarding short-term risk, ETAO is more volatile compared to CERT. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs PGNY Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, PGNY has a market cap of 1.8B. Regarding current trading prices, ETAO is priced at $1.91, while PGNY trades at $21.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas PGNY's P/E ratio is 37.25. In terms of profitability, ETAO's ROE is -13.69%, compared to PGNY's ROE of +0.12%. Regarding short-term risk, ETAO is more volatile compared to PGNY. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs GDRX Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, GDRX has a market cap of 1.8B. Regarding current trading prices, ETAO is priced at $1.91, while GDRX trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas GDRX's P/E ratio is 72.14. In terms of profitability, ETAO's ROE is -13.69%, compared to GDRX's ROE of +0.07%. Regarding short-term risk, ETAO is more volatile compared to GDRX. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs PINC Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, PINC has a market cap of 1.8B. Regarding current trading prices, ETAO is priced at $1.91, while PINC trades at $21.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas PINC's P/E ratio is 21.29. In terms of profitability, ETAO's ROE is -13.69%, compared to PINC's ROE of +0.03%. Regarding short-term risk, ETAO is more volatile compared to PINC. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs PHR Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, PHR has a market cap of 1.7B. Regarding current trading prices, ETAO is priced at $1.91, while PHR trades at $29.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas PHR's P/E ratio is -39.30. In terms of profitability, ETAO's ROE is -13.69%, compared to PHR's ROE of -0.16%. Regarding short-term risk, ETAO is more volatile compared to PHR. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs TXG Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, TXG has a market cap of 1.6B. Regarding current trading prices, ETAO is priced at $1.91, while TXG trades at $13.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas TXG's P/E ratio is -10.00. In terms of profitability, ETAO's ROE is -13.69%, compared to TXG's ROE of -0.22%. Regarding short-term risk, ETAO is more volatile compared to TXG. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs NXGN Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, ETAO is priced at $1.91, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas NXGN's P/E ratio is -266.00. In terms of profitability, ETAO's ROE is -13.69%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, ETAO is more volatile compared to NXGN. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SDGR Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SDGR has a market cap of 1.5B. Regarding current trading prices, ETAO is priced at $1.91, while SDGR trades at $20.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SDGR's P/E ratio is -7.97. In terms of profitability, ETAO's ROE is -13.69%, compared to SDGR's ROE of -0.45%. Regarding short-term risk, ETAO is more volatile compared to SDGR. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs TDOC Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, TDOC has a market cap of 1.5B. Regarding current trading prices, ETAO is priced at $1.91, while TDOC trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas TDOC's P/E ratio is -1.41. In terms of profitability, ETAO's ROE is -13.69%, compared to TDOC's ROE of -0.68%. Regarding short-term risk, ETAO is more volatile compared to TDOC. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs OMCL Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, OMCL has a market cap of 1.4B. Regarding current trading prices, ETAO is priced at $1.91, while OMCL trades at $29.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas OMCL's P/E ratio is 64.78. In terms of profitability, ETAO's ROE is -13.69%, compared to OMCL's ROE of +0.02%. Regarding short-term risk, ETAO is more volatile compared to OMCL. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs EVH Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, EVH has a market cap of 1.4B. Regarding current trading prices, ETAO is priced at $1.91, while EVH trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas EVH's P/E ratio is -9.61. In terms of profitability, ETAO's ROE is -13.69%, compared to EVH's ROE of -0.11%. Regarding short-term risk, ETAO is more volatile compared to EVH. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs AGTI Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, ETAO is priced at $1.91, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas AGTI's P/E ratio is -71.79. In terms of profitability, ETAO's ROE is -13.69%, compared to AGTI's ROE of -0.01%. Regarding short-term risk, ETAO is more volatile compared to AGTI. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs HSTM Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HSTM has a market cap of 846.6M. Regarding current trading prices, ETAO is priced at $1.91, while HSTM trades at $27.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HSTM's P/E ratio is 44.02. In terms of profitability, ETAO's ROE is -13.69%, compared to HSTM's ROE of +0.05%. Regarding short-term risk, ETAO is more volatile compared to HSTM. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs CTEV Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CTEV has a market cap of 698.2M. Regarding current trading prices, ETAO is priced at $1.91, while CTEV trades at $42.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CTEV's P/E ratio is -0.58. In terms of profitability, ETAO's ROE is -13.69%, compared to CTEV's ROE of -5.18%. Regarding short-term risk, ETAO is more volatile compared to CTEV. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs NUTX Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, NUTX has a market cap of 679.9M. Regarding current trading prices, ETAO is priced at $1.91, while NUTX trades at $122.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas NUTX's P/E ratio is 9.91. In terms of profitability, ETAO's ROE is -13.69%, compared to NUTX's ROE of +0.71%. Regarding short-term risk, ETAO is more volatile compared to NUTX. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs MPLN-WT Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, ETAO is priced at $1.91, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MPLN-WT's ROE of -5.18%. Regarding short-term risk, ETAO is less volatile compared to MPLN-WT. This indicates potentially lower risk in terms of short-term price fluctuations for ETAO.
ETAO vs ACCD Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, ETAO is priced at $1.91, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ACCD's P/E ratio is -3.08. In terms of profitability, ETAO's ROE is -13.69%, compared to ACCD's ROE of -0.45%. Regarding short-term risk, ETAO is more volatile compared to ACCD. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SHCR Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, ETAO is priced at $1.91, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SHCR's P/E ratio is -3.76. In terms of profitability, ETAO's ROE is -13.69%, compared to SHCR's ROE of -0.24%. Regarding short-term risk, ETAO is more volatile compared to SHCR. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs DH Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, DH has a market cap of 432.6M. Regarding current trading prices, ETAO is priced at $1.91, while DH trades at $4.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas DH's P/E ratio is -0.91. In terms of profitability, ETAO's ROE is -13.69%, compared to DH's ROE of -1.07%. Regarding short-term risk, ETAO is more volatile compared to DH. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SY Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SY has a market cap of 432.6M. Regarding current trading prices, ETAO is priced at $1.91, while SY trades at $3.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SY's P/E ratio is -4.10. In terms of profitability, ETAO's ROE is -13.69%, compared to SY's ROE of -0.28%. Regarding short-term risk, ETAO is more volatile compared to SY. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SLGCW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, ETAO is priced at $1.91, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, ETAO's ROE is -13.69%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, ETAO is more volatile compared to SLGCW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SLGC Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, ETAO is priced at $1.91, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SLGC's P/E ratio is -3.04. In terms of profitability, ETAO's ROE is -13.69%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, ETAO is more volatile compared to SLGC. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs NRC Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, NRC has a market cap of 376.4M. Regarding current trading prices, ETAO is priced at $1.91, while NRC trades at $16.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas NRC's P/E ratio is 16.20. In terms of profitability, ETAO's ROE is -13.69%, compared to NRC's ROE of +0.71%. Regarding short-term risk, ETAO is more volatile compared to NRC. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs MPLN Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, ETAO is priced at $1.91, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MPLN's P/E ratio is -0.23. In terms of profitability, ETAO's ROE is -13.69%, compared to MPLN's ROE of -5.18%. Regarding short-term risk, ETAO is more volatile compared to MPLN. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SLP Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SLP has a market cap of 368.6M. Regarding current trading prices, ETAO is priced at $1.91, while SLP trades at $18.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SLP's P/E ratio is 50.92. In terms of profitability, ETAO's ROE is -13.69%, compared to SLP's ROE of +0.04%. Regarding short-term risk, ETAO is more volatile compared to SLP. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SPOK Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SPOK has a market cap of 358.5M. Regarding current trading prices, ETAO is priced at $1.91, while SPOK trades at $17.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SPOK's P/E ratio is 22.63. In terms of profitability, ETAO's ROE is -13.69%, compared to SPOK's ROE of +0.10%. Regarding short-term risk, ETAO is more volatile compared to SPOK. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs TBRG Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, TBRG has a market cap of 340.4M. Regarding current trading prices, ETAO is priced at $1.91, while TBRG trades at $22.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas TBRG's P/E ratio is -18.57. In terms of profitability, ETAO's ROE is -13.69%, compared to TBRG's ROE of -0.10%. Regarding short-term risk, ETAO is more volatile compared to TBRG. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs TRHC Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, ETAO is priced at $1.91, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas TRHC's P/E ratio is -4.27. In terms of profitability, ETAO's ROE is -13.69%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, ETAO is more volatile compared to TRHC. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs HCAT Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HCAT has a market cap of 282.9M. Regarding current trading prices, ETAO is priced at $1.91, while HCAT trades at $4.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HCAT's P/E ratio is -3.53. In terms of profitability, ETAO's ROE is -13.69%, compared to HCAT's ROE of -0.20%. Regarding short-term risk, ETAO is more volatile compared to HCAT. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SMFR Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, ETAO is priced at $1.91, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SMFR's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to SMFR's ROE of -0.17%. Regarding short-term risk, ETAO is more volatile compared to SMFR. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs OPRX Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, OPRX has a market cap of 242.6M. Regarding current trading prices, ETAO is priced at $1.91, while OPRX trades at $13.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas OPRX's P/E ratio is -15.61. In terms of profitability, ETAO's ROE is -13.69%, compared to OPRX's ROE of -0.13%. Regarding short-term risk, ETAO is more volatile compared to OPRX. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SOPH Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SOPH has a market cap of 203.5M. Regarding current trading prices, ETAO is priced at $1.91, while SOPH trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SOPH's P/E ratio is -3.04. In terms of profitability, ETAO's ROE is -13.69%, compared to SOPH's ROE of -0.63%. Regarding short-term risk, ETAO is more volatile compared to SOPH. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs AMWL Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, AMWL has a market cap of 138.3M. Regarding current trading prices, ETAO is priced at $1.91, while AMWL trades at $8.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas AMWL's P/E ratio is -0.86. In terms of profitability, ETAO's ROE is -13.69%, compared to AMWL's ROE of -0.48%. Regarding short-term risk, ETAO is more volatile compared to AMWL. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs CPSI Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, ETAO is priced at $1.91, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CPSI's P/E ratio is -183.80. In terms of profitability, ETAO's ROE is -13.69%, compared to CPSI's ROE of -0.18%. Regarding short-term risk, ETAO is more volatile compared to CPSI. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs EUDA Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, EUDA has a market cap of 129.3M. Regarding current trading prices, ETAO is priced at $1.91, while EUDA trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas EUDA's P/E ratio is -6.44. In terms of profitability, ETAO's ROE is -13.69%, compared to EUDA's ROE of +3.05%. Regarding short-term risk, ETAO is more volatile compared to EUDA. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs AUGX Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, ETAO is priced at $1.91, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas AUGX's P/E ratio is -4.99. In terms of profitability, ETAO's ROE is -13.69%, compared to AUGX's ROE of -1.13%. Regarding short-term risk, ETAO is more volatile compared to AUGX. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs CCLD Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CCLD has a market cap of 103.3M. Regarding current trading prices, ETAO is priced at $1.91, while CCLD trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CCLD's P/E ratio is -11.09. In terms of profitability, ETAO's ROE is -13.69%, compared to CCLD's ROE of +0.21%. Regarding short-term risk, ETAO is more volatile compared to CCLD. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs CCLDO Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CCLDO has a market cap of 100.3M. Regarding current trading prices, ETAO is priced at $1.91, while CCLDO trades at $19.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CCLDO's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to CCLDO's ROE of +0.21%. Regarding short-term risk, ETAO is more volatile compared to CCLDO. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs BEATW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BEATW has a market cap of 64.8M. Regarding current trading prices, ETAO is priced at $1.91, while BEATW trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BEATW's P/E ratio is -0.98. In terms of profitability, ETAO's ROE is -13.69%, compared to BEATW's ROE of -3.58%. Regarding short-term risk, ETAO is less volatile compared to BEATW. This indicates potentially lower risk in terms of short-term price fluctuations for ETAO.
ETAO vs FORA Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, FORA has a market cap of 61.5M. Regarding current trading prices, ETAO is priced at $1.91, while FORA trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas FORA's P/E ratio is -16.42. In terms of profitability, ETAO's ROE is -13.69%, compared to FORA's ROE of -0.13%. Regarding short-term risk, ETAO is more volatile compared to FORA. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs CCLDP Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, ETAO is priced at $1.91, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CCLDP's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to CCLDP's ROE of +0.21%. Regarding short-term risk, ETAO is more volatile compared to CCLDP. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs BEAT Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BEAT has a market cap of 41.9M. Regarding current trading prices, ETAO is priced at $1.91, while BEAT trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BEAT's P/E ratio is -1.68. In terms of profitability, ETAO's ROE is -13.69%, compared to BEAT's ROE of -3.58%. Regarding short-term risk, ETAO is more volatile compared to BEAT. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SNCE Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, ETAO is priced at $1.91, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SNCE's P/E ratio is -0.27. In terms of profitability, ETAO's ROE is -13.69%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, ETAO is more volatile compared to SNCE. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs AKLI Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, ETAO is priced at $1.91, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas AKLI's P/E ratio is -0.71. In terms of profitability, ETAO's ROE is -13.69%, compared to AKLI's ROE of -0.38%. Regarding short-term risk, ETAO is more volatile compared to AKLI. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SHLT Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, ETAO is priced at $1.91, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SHLT's P/E ratio is -3.87. In terms of profitability, ETAO's ROE is -13.69%, compared to SHLT's ROE of -0.09%. Regarding short-term risk, ETAO is more volatile compared to SHLT. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SHCRW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, ETAO is priced at $1.91, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, ETAO's ROE is -13.69%, compared to SHCRW's ROE of -0.24%. Regarding short-term risk, ETAO is more volatile compared to SHCRW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs STRM Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, STRM has a market cap of 22.7M. Regarding current trading prices, ETAO is priced at $1.91, while STRM trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas STRM's P/E ratio is -2.34. In terms of profitability, ETAO's ROE is -13.69%, compared to STRM's ROE of -0.68%. Regarding short-term risk, ETAO is more volatile compared to STRM. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs VSEEW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, VSEEW has a market cap of 22.6M. Regarding current trading prices, ETAO is priced at $1.91, while VSEEW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas VSEEW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to VSEEW's ROE of -6.10%. Regarding short-term risk, ETAO is more volatile compared to VSEEW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs RNLX Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, ETAO is priced at $1.91, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas RNLX's P/E ratio is -0.33. In terms of profitability, ETAO's ROE is -13.69%, compared to RNLX's ROE of +2.93%. Regarding short-term risk, ETAO is more volatile compared to RNLX. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs LIFW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, ETAO is priced at $1.91, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas LIFW's P/E ratio is -0.02. In terms of profitability, ETAO's ROE is -13.69%, compared to LIFW's ROE of -3.08%. Regarding short-term risk, ETAO is more volatile compared to LIFW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs SCNX Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, SCNX has a market cap of 18.9M. Regarding current trading prices, ETAO is priced at $1.91, while SCNX trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas SCNX's P/E ratio is 2.32. In terms of profitability, ETAO's ROE is -13.69%, compared to SCNX's ROE of +0.19%. Regarding short-term risk, ETAO is more volatile compared to SCNX. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs VSEE Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, VSEE has a market cap of 18.5M. Regarding current trading prices, ETAO is priced at $1.91, while VSEE trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas VSEE's P/E ratio is -14.75. In terms of profitability, ETAO's ROE is -13.69%, compared to VSEE's ROE of -6.10%. Regarding short-term risk, ETAO is more volatile compared to VSEE. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs ONMD Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ONMD has a market cap of 18M. Regarding current trading prices, ETAO is priced at $1.91, while ONMD trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ONMD's P/E ratio is -1.73. In terms of profitability, ETAO's ROE is -13.69%, compared to ONMD's ROE of +0.60%. Regarding short-term risk, ETAO is more volatile compared to ONMD. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs MGRX Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MGRX has a market cap of 15M. Regarding current trading prices, ETAO is priced at $1.91, while MGRX trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MGRX's P/E ratio is -0.33. In terms of profitability, ETAO's ROE is -13.69%, compared to MGRX's ROE of -0.73%. Regarding short-term risk, ETAO is more volatile compared to MGRX. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs BFRG Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BFRG has a market cap of 15M. Regarding current trading prices, ETAO is priced at $1.91, while BFRG trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BFRG's P/E ratio is -1.99. In terms of profitability, ETAO's ROE is -13.69%, compared to BFRG's ROE of -1.63%. Regarding short-term risk, ETAO is more volatile compared to BFRG. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs BFRGW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BFRGW has a market cap of 14.3M. Regarding current trading prices, ETAO is priced at $1.91, while BFRGW trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BFRGW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to BFRGW's ROE of -1.33%. Regarding short-term risk, ETAO is more volatile compared to BFRGW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs BBLN Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, ETAO is priced at $1.91, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas BBLN's P/E ratio is -0.04. In terms of profitability, ETAO's ROE is -13.69%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, ETAO is more volatile compared to BBLN. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs INOV Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, INOV has a market cap of 12.8M. Regarding current trading prices, ETAO is priced at $1.91, while INOV trades at $32.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas INOV's P/E ratio is 16.46. In terms of profitability, ETAO's ROE is -13.69%, compared to INOV's ROE of +0.03%. Regarding short-term risk, ETAO is more volatile compared to INOV. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs HCTI Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HCTI has a market cap of 9.9M. Regarding current trading prices, ETAO is priced at $1.91, while HCTI trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HCTI's P/E ratio is -0.03. In terms of profitability, ETAO's ROE is -13.69%, compared to HCTI's ROE of -23.25%. Regarding short-term risk, ETAO is more volatile compared to HCTI. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs MSPR Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MSPR has a market cap of 8.9M. Regarding current trading prices, ETAO is priced at $1.91, while MSPR trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MSPR's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MSPR's ROE of -3.08%. Regarding short-term risk, ETAO is more volatile compared to MSPR. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs HLTH Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, ETAO is priced at $1.91, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas HLTH's P/E ratio is -0.02. In terms of profitability, ETAO's ROE is -13.69%, compared to HLTH's ROE of -0.88%. Regarding short-term risk, ETAO is more volatile compared to HLTH. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs ZCMD Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ZCMD has a market cap of 6.1M. Regarding current trading prices, ETAO is priced at $1.91, while ZCMD trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ZCMD's P/E ratio is -9.75. In terms of profitability, ETAO's ROE is -13.69%, compared to ZCMD's ROE of -0.03%. Regarding short-term risk, ETAO is more volatile compared to ZCMD. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs UPH Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, ETAO is priced at $1.91, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas UPH's P/E ratio is -0.07. In terms of profitability, ETAO's ROE is -13.69%, compared to UPH's ROE of -1.05%. Regarding short-term risk, ETAO is more volatile compared to UPH. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs FOXO Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, FOXO has a market cap of 5.3M. Regarding current trading prices, ETAO is priced at $1.91, while FOXO trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas FOXO's P/E ratio is -0.02. In terms of profitability, ETAO's ROE is -13.69%, compared to FOXO's ROE of -0.01%. Regarding short-term risk, ETAO is more volatile compared to FOXO. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs ACON Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ACON has a market cap of 4.4M. Regarding current trading prices, ETAO is priced at $1.91, while ACON trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ACON's P/E ratio is -0.66. In terms of profitability, ETAO's ROE is -13.69%, compared to ACON's ROE of -1.27%. Regarding short-term risk, ETAO is more volatile compared to ACON. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs PEAR Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, ETAO is priced at $1.91, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas PEAR's P/E ratio is -0.08. In terms of profitability, ETAO's ROE is -13.69%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, ETAO is more volatile compared to PEAR. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs PEARW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, ETAO is priced at $1.91, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas PEARW's P/E ratio is -0.00. In terms of profitability, ETAO's ROE is -13.69%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, ETAO is more volatile compared to PEARW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs EUDAW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, EUDAW has a market cap of 4.1M. Regarding current trading prices, ETAO is priced at $1.91, while EUDAW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas EUDAW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to EUDAW's ROE of +3.05%. Regarding short-term risk, ETAO is more volatile compared to EUDAW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs OTRK Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, OTRK has a market cap of 2M. Regarding current trading prices, ETAO is priced at $1.91, while OTRK trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas OTRK's P/E ratio is -0.03. In terms of profitability, ETAO's ROE is -13.69%, compared to OTRK's ROE of -2.70%. Regarding short-term risk, ETAO is more volatile compared to OTRK. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs WGSWW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, WGSWW has a market cap of 1.8M. Regarding current trading prices, ETAO is priced at $1.91, while WGSWW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas WGSWW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to WGSWW's ROE of -0.17%. Regarding short-term risk, ETAO is more volatile compared to WGSWW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs WORX Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, WORX has a market cap of 1.7M. Regarding current trading prices, ETAO is priced at $1.91, while WORX trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas WORX's P/E ratio is -0.52. In terms of profitability, ETAO's ROE is -13.69%, compared to WORX's ROE of -0.32%. Regarding short-term risk, ETAO is more volatile compared to WORX. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs CMAX Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, ETAO is priced at $1.91, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CMAX's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to CMAX's ROE of +30.94%. Regarding short-term risk, ETAO is more volatile compared to CMAX. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs LIFWZ Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, ETAO is priced at $1.91, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to LIFWZ's ROE of -3.08%. Regarding short-term risk, ETAO is more volatile compared to LIFWZ. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs OTRKP Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, OTRKP has a market cap of 1.1M. Regarding current trading prices, ETAO is priced at $1.91, while OTRKP trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas OTRKP's P/E ratio is -0.08. In terms of profitability, ETAO's ROE is -13.69%, compared to OTRKP's ROE of -2.70%. Regarding short-term risk, ETAO is more volatile compared to OTRKP. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs ICCT Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ICCT has a market cap of 829.1K. Regarding current trading prices, ETAO is priced at $1.91, while ICCT trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ICCT's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to ICCT's ROE of +20.01%. Regarding short-term risk, ETAO is more volatile compared to ICCT. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs KERN Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, ETAO is priced at $1.91, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas KERN's P/E ratio is -0.01. In terms of profitability, ETAO's ROE is -13.69%, compared to KERN's ROE of -2.22%. Regarding short-term risk, ETAO is more volatile compared to KERN. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs KERNW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, ETAO is priced at $1.91, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas KERNW's P/E ratio is -0.00. In terms of profitability, ETAO's ROE is -13.69%, compared to KERNW's ROE of -2.22%. Regarding short-term risk, ETAO is less volatile compared to KERNW. This indicates potentially lower risk in terms of short-term price fluctuations for ETAO.
ETAO vs MSPRZ Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MSPRZ has a market cap of 116.1K. Regarding current trading prices, ETAO is priced at $1.91, while MSPRZ trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MSPRZ's ROE of -3.08%. Regarding short-term risk, ETAO is more volatile compared to MSPRZ. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs LIFWW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, ETAO is priced at $1.91, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas LIFWW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to LIFWW's ROE of -3.08%. Regarding short-term risk, ETAO is more volatile compared to LIFWW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs CMAXW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, ETAO is priced at $1.91, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CMAXW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to CMAXW's ROE of +30.94%. Regarding short-term risk, ETAO is more volatile compared to CMAXW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs ACONW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, ACONW has a market cap of 18.6K. Regarding current trading prices, ETAO is priced at $1.91, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas ACONW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to ACONW's ROE of -1.27%. Regarding short-term risk, ETAO is more volatile compared to ACONW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs MSPRW Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MSPRW has a market cap of 7.3K. Regarding current trading prices, ETAO is priced at $1.91, while MSPRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MSPRW's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MSPRW's ROE of -3.08%. Regarding short-term risk, ETAO is more volatile compared to MSPRW. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs UTRS Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, UTRS has a market cap of 888. Regarding current trading prices, ETAO is priced at $1.91, while UTRS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas UTRS's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to UTRS's ROE of -1.11%. Regarding short-term risk, ETAO is more volatile compared to UTRS. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs CSLT Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CSLT's P/E ratio is -37.27. In terms of profitability, ETAO's ROE is -13.69%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, ETAO is more volatile compared to CSLT. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs MTBCO Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas MTBCO's P/E ratio is N/A. In terms of profitability, ETAO's ROE is -13.69%, compared to MTBCO's ROE of +0.21%. Regarding short-term risk, ETAO is more volatile compared to MTBCO. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs CERN Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, CERN has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas CERN's P/E ratio is 55.84. In terms of profitability, ETAO's ROE is -13.69%, compared to CERN's ROE of +0.14%. Regarding short-term risk, ETAO is more volatile compared to CERN. This indicates potentially higher risk in terms of short-term price fluctuations for ETAO.
ETAO vs NH Comparison
ETAO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ETAO stands at 9.8M. In comparison, NH has a market cap of 0. Regarding current trading prices, ETAO is priced at $1.91, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ETAO currently has a P/E ratio of -0.01, whereas NH's P/E ratio is -0.12. In terms of profitability, ETAO's ROE is -13.69%, compared to NH's ROE of +0.35%. Regarding short-term risk, ETAO is less volatile compared to NH. This indicates potentially lower risk in terms of short-term price fluctuations for ETAO.